LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

LLY

715.06

-1.34%↓

JNJ

152.52

-0.44%↓

ABBV

182.34

+0.35%↑

NVO

68.13

-0.07%↓

UNH

296.46

-2.25%↓

Search

Bio-Rad Laboratories Inc

Geschlossen

BrancheGesundheitswesen

226.67 -0.36

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

221.09

Max

228.07

Schlüsselkennzahlen

By Trading Economics

Einkommen

780M

64M

Verkäufe

-82M

585M

EPS

2.54

Gewinnspanne

10.933

Angestellte

7,700

EBITDA

75M

134M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+40.98% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

31. Juli 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

167M

6.7B

Vorheriger Eröffnungskurs

227.03

Vorheriger Schlusskurs

226.67

Nachrichtenstimmung

By Acuity

50%

50%

174 / 382 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

Bio-Rad Laboratories Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

22. Mai 2025, 23:48 UTC

Heiße Aktien

Stocks to Watch: Deckers Outdoor, Intuit, Ross Stores, Lightbridge, NuScale Power, Centrus Energy

22. Mai 2025, 23:07 UTC

Top News

Fortescue Energy CEO to Resign in Executive Overhaul

22. Mai 2025, 23:03 UTC

Wichtige Markttreiber

Nuclear-Industry Stocks Get Boost After Report Says Trump Will Sign Orders to Jumpstart Field

22. Mai 2025, 23:59 UTC

Market Talk

Gold Edges Higher, Supported by Lingering Worries Over U.S. Deficits -- Market Talk

22. Mai 2025, 23:45 UTC

Market Talk

Nikkei May Trade in Range as Uncertainty Over Tariffs Continues -- Market Talk

22. Mai 2025, 23:45 UTC

Market Talk

Global Equities Roundup: Market Talk

22. Mai 2025, 23:23 UTC

Market Talk

Global Energy Roundup: Market Talk

22. Mai 2025, 23:23 UTC

Market Talk

Fortescue Iron Bridge Delay Disappoints; Executive Changes Welcomed -- Market Talk

22. Mai 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

22. Mai 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

22. Mai 2025, 20:46 UTC

Akquisitionen, Fusionen, Übernahmen

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

22. Mai 2025, 20:39 UTC

Ergebnisse

Tesla's Emissions Credits Are at Risk After Senate's California Vote -- Barrons.com

22. Mai 2025, 20:36 UTC

Top News

Antitrust Cops Say BlackRock, Other Fund Giants May Have Harmed Energy Competition -- 4th Update

22. Mai 2025, 20:36 UTC

Top News
Ergebnisse

Workday Logs Higher 1Q Revenue, Backs Outlook; Initiates $1B Buyback Program

22. Mai 2025, 20:32 UTC

Top News
Ergebnisse

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22. Mai 2025, 20:27 UTC

Top News

Trump's 'Big, Beautiful Bill' Heads to Senate, Where New Fights Loom -- WSJ

22. Mai 2025, 20:20 UTC

Top News

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22. Mai 2025, 20:17 UTC

Top News

The Deficit Is Unsettling Bond Traders. Here's How That Affects the Economy. -- 2nd Update

22. Mai 2025, 20:16 UTC

Ergebnisse

Intchains Group 1Q Rev $18.2M >ICG

22. Mai 2025, 20:15 UTC

Top News

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22. Mai 2025, 20:08 UTC

Top News
Ergebnisse

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22. Mai 2025, 20:05 UTC

Top News

Intuit Seeing Stable Environment for Consumers, Businesses While Tariffs Play Out

22. Mai 2025, 20:04 UTC

Ergebnisse

Workday Sees FY26 Subscription Revenue $8.8B >WDAY

22. Mai 2025, 20:04 UTC

Ergebnisse

Workday Sees 2Q Subscription Revenue $2.16B >WDAY

22. Mai 2025, 20:01 UTC

Ergebnisse

Intuit Sees FY25 EPS $13.19-EPS $12.24 >INTU

22. Mai 2025, 20:01 UTC

Ergebnisse

Workday 1Q Net $68M >WDAY

22. Mai 2025, 20:01 UTC

Ergebnisse

Workday 1Q EPS 25c >WDAY

22. Mai 2025, 20:01 UTC

Ergebnisse

Workday 1Q Adj EPS $2.23 >WDAY

22. Mai 2025, 20:01 UTC

Ergebnisse

Workday 1Q Subscription Revenue $2.06B >WDAY

22. Mai 2025, 20:01 UTC

Ergebnisse

Workday 1Q Rev $2.24B >WDAY

Peer-Vergleich

Kursveränderung

Bio-Rad Laboratories Inc Prognose

Kursziel

By TipRanks

40.98% Vorteil

12-Monats-Prognose

Durchschnitt 321.4 USD  40.98%

Hoch 392 USD

Tief 270 USD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Bio-Rad Laboratories Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

5 ratings

3

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

229.835 / 235.8095Unterstützung & Widerstand

Kurzfristig

Very Strong Bearish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Bearish Evidence

Stimmung

By Acuity

174 / 382 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.